127 related articles for article (PubMed ID: 1354544)
21. Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons.
Wu YN; Shen KZ; Johnson SW
Br J Pharmacol; 1999 Jul; 127(6):1422-30. PubMed ID: 10455292
[TBL] [Abstract][Full Text] [Related]
22. Glutamatergic regulation of histamine release from rat hypothalamus.
Okakura K; Yamatodani A; Mochizuki T; Horii A; Wada H
Eur J Pharmacol; 1992 Mar; 213(2):189-92. PubMed ID: 1381677
[TBL] [Abstract][Full Text] [Related]
23. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats.
Watts J; Segieth J; Pearce B; Whitton PS
Neurosci Lett; 2004 Mar; 357(3):179-82. PubMed ID: 15003279
[TBL] [Abstract][Full Text] [Related]
24. The paradoxical effect of NMDA receptor stimulation on electrical activity of the sensorimotor cortex in freely behaving rats: analysis by combined EEG-intracerebral microdialysis.
Ludvig N; Mishra PK; Yan QS; Lasley SM; Burger RL; Jobe PC
Synapse; 1992 Oct; 12(2):87-98. PubMed ID: 1362291
[TBL] [Abstract][Full Text] [Related]
25. Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum.
Pazzagli M; Pedata F; Pepeu G
Eur J Pharmacol; 1993 Mar; 234(1):61-5. PubMed ID: 8472761
[TBL] [Abstract][Full Text] [Related]
26. N-methyl-D-aspartate-evoked release of cyclo-oxygenase products in rabbit hippocampus: an in vivo microdialysis study.
Lazarewicz JW; Salińska E
J Neurosci Res; 1995 Apr; 40(5):660-6. PubMed ID: 7602616
[TBL] [Abstract][Full Text] [Related]
27. Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures.
Smith KJ; Self RL; Butler TR; Mullins MM; Ghayoumi L; Holley RC; Littleton JM; Prendergast MA
Brain Res; 2007 Jul; 1157():74-80. PubMed ID: 17524372
[TBL] [Abstract][Full Text] [Related]
28. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons.
Benveniste M; Mienville JM; Sernagor E; Mayer ML
J Neurophysiol; 1990 Jun; 63(6):1373-84. PubMed ID: 1972740
[TBL] [Abstract][Full Text] [Related]
29. NMDA-Independent LTP by adenosine A2 receptor-mediated postsynaptic AMPA potentiation in hippocampus.
Kessey K; Mogul DJ
J Neurophysiol; 1997 Oct; 78(4):1965-72. PubMed ID: 9325364
[TBL] [Abstract][Full Text] [Related]
30. In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors.
Pazzagli M; Corsi C; Latini S; Pedata F; Pepeu G
Eur J Pharmacol; 1994 Mar; 254(3):277-82. PubMed ID: 8013563
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
32. Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study.
Knauber J; Kischka U; Roth M; Schmidt WJ; Hennerici M; Fassbender K
J Neural Transm (Vienna); 1999; 106(1):35-45. PubMed ID: 10195333
[TBL] [Abstract][Full Text] [Related]
33. Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
Hebb MO; White TD
Eur J Pharmacol; 1998 Mar; 344(2-3):121-5. PubMed ID: 9600645
[TBL] [Abstract][Full Text] [Related]
34. NMDA receptor involvement in endothelin neurotoxicity in rat striatal slices.
Kataoka Y; Koizumi S; Kohzuma M; Shibaguchi H; Shigematsu K; Niwa M; Taniyama K
Eur J Pharmacol; 1995 Feb; 273(3):285-9. PubMed ID: 7537685
[TBL] [Abstract][Full Text] [Related]
35. Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo.
Bhardwaj A; Northington FJ; Martin LJ; Hanley DF; Traystman RJ; Koehler RC
J Cereb Blood Flow Metab; 1997 Feb; 17(2):153-60. PubMed ID: 9040494
[TBL] [Abstract][Full Text] [Related]
36. Effect of protein kinase C activation on N-methyl-D-aspartate-evoked release of adenosine and [3H]Norepinephrine from rat cortical slices.
Wang Y; White TD
J Pharmacol Exp Ther; 1998 Apr; 285(1):105-9. PubMed ID: 9535999
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
Mount H; Quirion R; Chaudieu I; Boksa P
Mol Pharmacol; 1991 Feb; 39(2):205-10. PubMed ID: 1825345
[TBL] [Abstract][Full Text] [Related]
38. NMDA receptor agonists selectively block N-type calcium channels in hippocampal neurons.
Chernevskaya NI; Obukhov AG; Krishtal OA
Nature; 1991 Jan; 349(6308):418-20. PubMed ID: 1671527
[TBL] [Abstract][Full Text] [Related]
39. In vivo studies on NMDA-evoked release of amino acids in the rat spinal cord.
Sundström E; Mo LL; Seiger A
Neurochem Int; 1995 Aug; 27(2):185-93. PubMed ID: 7580874
[TBL] [Abstract][Full Text] [Related]
40. Adenosine transport inhibitors enhance high K(+)-evoked taurine release from rat hippocampus.
Hada J; Kaku T; Morimoto K; Hayashi Y; Nagai K
Eur J Pharmacol; 1996 Jun; 305(1-3):101-7. PubMed ID: 8813538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
